Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283777 · ClinicalTrials.gov registry record · Phase 4
Chromium and Insulin Action
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00283777 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 30 participants.
The verdict
NCT00283777, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The effect of Chromium to improve glucose levels in diabetes is controversial. The hypothesis of the study was to evaluate the effect of supplementing the diet of individuals with Type 2 diabetes with chromium picolinate and assessing the effect on blood glucose levels and insulin sensitivity
Interventions
- DRUG Chromium Picolinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1998-08 |
| Est. Completion | 2003-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283777
The ClinicalTrials.gov registry entry for NCT00283777 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chromium Picolinate is the first listed.
NCT00283777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00283777 about?
NCT00283777 is a clinical study titled "Chromium and Insulin Action". The effect of Chromium to improve glucose levels in diabetes is controversial. The hypothesis of the study was to evaluate the effect of supplementing the diet of individuals with Type 2 diabetes with chromium picolinate and assessing the effect on blood glucose levels and insulin sensitivity
What is the current status of trial NCT00283777?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 1998-08. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00283777?
The interventions under investigation include: Chromium Picolinate (DRUG).
Who is sponsoring clinical trial NCT00283777?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.